These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of interferon-alpha and granulocyte colony-stimulating factor in hairy cell leukaemia with aplastic marrow. Osterholz J; Wohlleber M; Kahnt C; Schumacher K Eur J Haematol; 1995 Aug; 55(2):140-2. PubMed ID: 7543058 [No Abstract] [Full Text] [Related]
3. Immunoglobulin A nephropathy associated with hairy cell leukaemia: a case report. Yu F; Zhang LX; Liu G; Zhao MH; Wang HY Nephrology (Carlton); 2010 Jun; 15(4):503-4. PubMed ID: 20609106 [No Abstract] [Full Text] [Related]
4. Therapeutic advances in the treatment of hairy cell leukemia. Andrey J; Saven A Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103 [No Abstract] [Full Text] [Related]
5. Interferon alfa-2a tretinoin in patients with metastatic renal cell carcinoma: a pilot study. Paule B; Bonhomme-Faivre L; Rudant E; Ferrière F Am J Health Syst Pharm; 1997 Jan; 54(2):190-2. PubMed ID: 9117809 [No Abstract] [Full Text] [Related]
6. Interferon in the treatment of hairy-cell leukemia. Ahmed S; Rai KR Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466 [TBL] [Abstract][Full Text] [Related]
7. Interferon for metastatic renal cell cancer causing regression of hereditary hemorrhagic telangiectasia. Wheatley-Price P; Shovlin C; Chao D J Clin Gastroenterol; 2005 Apr; 39(4):344-5. PubMed ID: 15758631 [No Abstract] [Full Text] [Related]
8. Cutaneous metastasis to face and neck as a sole manifestation of an unsuspected renal cell carcinoma. Chauhan A; Ganguly M; Nath P; Chowdhary GS Int J Dermatol; 2011 Jan; 50(1):81-4. PubMed ID: 21182508 [No Abstract] [Full Text] [Related]
9. [A case of renal cell carcinoma in horseshoe kidney]. Otero-García JM; Maldonado-Alcaraz E; López-Sámano VA Gac Med Mex; 2005; 141(4):305-7. PubMed ID: 16164126 [TBL] [Abstract][Full Text] [Related]
10. Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia. Couban S; Wilson WE Am J Hematol; 1995 Jul; 49(3):255-6. PubMed ID: 7541605 [No Abstract] [Full Text] [Related]
11. Digging deep: high output heart failure in renal cell carcinoma. Hayek S; Kung R; Barb I; Master V; Al S; Clements S Am J Med; 2014 Jan; 127(1):22-4. PubMed ID: 24262803 [No Abstract] [Full Text] [Related]
12. The disease with hope: hairy cell leukemia. Becker SE Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181 [TBL] [Abstract][Full Text] [Related]
13. Association of membranoproliferative glomerulonephritis with renal cell carcinoma. Mogili HK; Cv Kumar A; Boju SL; Rapur R; V SK Nephrology (Carlton); 2017 Jan; 22(1):95-96. PubMed ID: 28004485 [No Abstract] [Full Text] [Related]
14. Role of ultrasound in the investigation of haematuria after normal intravenous urography and cystoscopy. Loosemore TM; Woodhouse CR; Shearer RJ Eur Urol; 1991; 19(1):6-7. PubMed ID: 2007421 [TBL] [Abstract][Full Text] [Related]
15. Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy. Donadieu J; Barkaoui M; Bézard F; Bertrand Y; Pondarré C; Guibaud P J Pediatr Hematol Oncol; 2000; 22(2):188-9. PubMed ID: 10779042 [No Abstract] [Full Text] [Related]